focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,966.00
Bid: 2,967.00
Ask: 2,969.00
Change: 16.00 (0.54%)
Spread: 2.00 (0.067%)
Open: 2,966.00
High: 2,978.00
Low: 2,939.00
Prev. Close: 2,950.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on portfolio and Capital Markets Seminar

20 Sep 2023 07:00

RNS Number : 9802M
3i Group PLC
20 September 2023
 

 

Press release

20 September 2023

 

3i Group plc

Update on portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on nexeye and European Bakery Group, two of our Private Equity investments, as well as on our in-house Private Equity Banking Team. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio more broadly, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

 

We have completed our September semi-annual portfolio company reviews for Private Equity and Infrastructure. Our investment portfolios continue to make good progress against a difficult macroeconomic backdrop. In our Private Equity portfolio, assets in the value-for-money consumer and private label, healthcare, speciality industrial and technology services sectors are generating resilient earnings growth and are showing positive momentum as we head into the second half of our financial year. Our travel related assets have seen a sustained increase in demand. Luqom and YDEON continue to face a challenging sales environment following the Covid lockdown period. Tato, Formel D and Wilson are also dealing with weaker end markets and the resulting reduction in customer demand. 3i's strong active asset management processes continue to be a key part of how we mitigate the impact of today's market challenges.

 

Action's impressive performance has continued with very strong sales and EBITDA growth. Year-to-date sales (at 17 September 2023) of €7.5 billion are now 31% ahead of the same period last year. LFL sales growth over the same period was 20%, driven primarily by high customer footfall. As previously indicated LFL performance comparisons will be more challenging for the remainder of the current calendar year. Action continues to attract significant new customer flow through very low prices and good product availability in store, with strong performance across all geographies and categories. We expect operating EBITDA for the 12 months to the end of P9 2023 to be circa €1,530 million compared to €1,036 million at the end of September 2022. Cash generation has continued to be strong, with cash balances at 17 September 2023 at €1,014 million. Action has now added 140 net new stores in the year to date and remains on track to add circa 300 stores in 2023.

 

 

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit https://www.3i.com/investor-relations/capital-markets-presentations/2023/

 

- Ends-

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXNNFFSDEFA
Date   Source Headline
13th May 20217:00 amRNSDirectorate Change
13th May 20217:00 amRNSResults for the year to 31 March 2021
30th Apr 20214:09 pmRNSTotal Voting Rights
30th Apr 20214:07 pmRNSDirector/PDMR Shareholding
1st Apr 202110:01 amRNSDirector Declaration
1st Apr 20218:39 amRNSPortfolio Update
31st Mar 20214:50 pmRNSTotal Voting Rights
31st Mar 20214:45 pmRNSDirector/PDMR Shareholding
19th Mar 20213:05 pmRNSDirector Declaration
18th Mar 20217:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 20214:51 pmRNSDirector/PDMR Shareholding
26th Feb 20212:40 pmRNSTotal Voting Rights
26th Feb 20212:37 pmRNSDirector/PDMR Shareholding
8th Feb 20214:57 pmRNSDirector/PDMR Shareholding
29th Jan 20214:30 pmRNSTotal Voting Rights
29th Jan 20214:29 pmRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSQ3 Performance update
5th Jan 20213:13 pmRNSTotal Voting Rights
5th Jan 20213:10 pmRNSDirector/PDMR Shareholding
5th Jan 20211:52 pmRNSPortfolio Update
21st Dec 202011:58 amRNSHolding(s) in Company - Replacement
21st Dec 202010:38 amRNSHolding(s) in Company
18th Dec 20209:03 amRNSDirector Declaration
17th Dec 20202:58 pmRNSDirectorate Change
16th Dec 20205:04 pmRNSDirector/PDMR Shareholding
11th Dec 20208:28 amRNSDirectorate Change
10th Dec 20202:21 pmRNSBlock listing Interim Review
30th Nov 20202:20 pmRNSDirector/PDMR Shareholding
30th Nov 20202:20 pmRNSTotal Voting Rights
12th Nov 202011:35 amRNSDoc re. Half Yearly Report 2020
12th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:56 pmRNSTotal Voting Rights
30th Oct 20201:54 pmRNSDirector/PDMR Shareholding
1st Oct 20201:46 pmRNSPortfolio Update
30th Sep 20205:25 pmRNSTotal Voting Rights
30th Sep 20205:23 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSPortfolio update and Capital Markets Seminar
8th Sep 20202:28 pmRNSDirector/PDMR Shareholding
28th Aug 20202:50 pmRNSTotal Voting Rights
28th Aug 20202:47 pmRNSDirector/PDMR Shareholding
4th Aug 20202:36 pmRNSDirector/PDMR Shareholding
31st Jul 20203:41 pmRNSTotal Voting Rights
31st Jul 20202:40 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSQ1 performance update
16th Jul 20202:22 pmRNSPortfolio Update
1st Jul 20203:00 pmRNSDirector/PDMR Shareholding
30th Jun 20204:17 pmRNSTotal Voting Rights
30th Jun 20204:17 pmRNSDirector/PDMR Shareholding
30th Jun 20202:08 pmRNSDirector/PDMR Shareholding
26th Jun 20205:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.